Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 14 of 1714:
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, L type, alpha 1S subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, alpha 1F subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, beta 1 subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase PRAVASTATIN HMG-CoA Reductase 100% .005591uM NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase PRAVASTATIN HMG-CoA Reductase 100% .005591uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A EBASTINE Serotonin 5-HT2A 100% .0904uM .0258uM View
sodium channel, voltage-gated, type IV, beta EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel associated protein 1 EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel associated protein 2 EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type III, beta EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type I, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type IX, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type VII, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
amiloride-sensitive cation channel 5, intestinal EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type III, beta EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type XI, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type I, beta EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type 10, alpha polypeptide EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type IV, alpha polypeptide EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type V, alpha polypeptide EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type II, beta EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, nonvoltage-gated 1 alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, nonvoltage-gated 1 gamma EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, nonvoltage-gated 1 beta EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type XI, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, nonvoltage-gated 1, gamma EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, nonvoltage-gated 1, delta EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, nonvoltage-gated 1 alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type X, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type IX, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage gated, type VIII, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type VII, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type IV, beta EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type IV, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type III, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type II, beta EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type II, alpha 2 EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type I, beta EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
sodium channel, voltage-gated, type I, alpha EBASTINE Sodium Channel, Site 2 100% .0395uM .036uM View
cholinergic receptor, muscarinic 4 ORPHENADRINE Muscarinic M4 100% .125uM .017uM View
calcium channel, voltage-dependent, gamma subunit 8 EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, gamma subunit 7 EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, gamma subunit 6 EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, gamma subunit 5 EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
sodium channel, voltage gated, type VIII, alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type VII, alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type IV, beta BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type IV, alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type III, alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type II, beta BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type II, alpha 2 BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type I, beta BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type I, alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
adrenergic receptor, alpha 2b PHENTOLAMINE Adrenergic alpha2B 100% .018uM .008228uM View
adrenergic receptor, alpha 2b CANDESARTAN Adrenergic alpha2B 100% 3.843uM 1.7544uM View
adrenergic receptor, alpha 1a PHENTOLAMINE Adrenergic alpha1A 100% .011uM .004655uM View
adrenergic receptor, alpha 1b PHENTOLAMINE Adrenergic alpha1B 100% .082uM .045uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 BENZETHONIUM CHLORIDE Dopamine Transporter 100% 1.365uM 1.085uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 RALOXIFENE Adrenergic, Norepinephrine Transporter 100% .282uM .28uM View
5-hydroxytryptamine (serotonin) receptor 2B DAPIPRAZOLE Serotonin 5-HT2B 100% 1.056uM .672uM View
adrenergic receptor, alpha 1a DAPIPRAZOLE Adrenergic alpha1A 100% .095uM .039uM View
estrogen receptor 1 RALOXIFENE Estrogen ERalpha 100% .000553uM .000158uM View
estrogen receptor 1 RALOXIFENE Estrogen ERalpha 100% .000553uM .000158uM View
cholinergic receptor, muscarinic 1 CETYLPYRIDINIUM BROMIDE Muscarinic M1 100% .033uM .007941uM View
androgen receptor STANOZOLOL Testosterone 100% .022uM .015uM View
calcium channel, voltage-dependent, gamma subunit 8 LACIDIPINE Calcium Channel Type L, Dihydropyridine 100% .0004uM .000257uM View
sodium channel, voltage-gated, type IX, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type VII, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
amiloride-sensitive cation channel 5, intestinal DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type III, beta DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type XI, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type I, beta DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type 10, alpha polypeptide DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type IV, alpha polypeptide DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type V, alpha polypeptide DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type II, beta DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, nonvoltage-gated 1 alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, nonvoltage-gated 1 gamma DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, nonvoltage-gated 1 beta DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type XI, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, nonvoltage-gated 1, gamma DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, nonvoltage-gated 1, delta DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, nonvoltage-gated 1 alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type X, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type IX, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage gated, type VIII, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type VII, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type IV, beta DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type IV, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type III, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type II, beta DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type II, alpha 2 DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type I, beta DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
sodium channel, voltage-gated, type I, alpha DOXAZOSIN Sodium Channel, Site 2 100% 1.1uM 1.003uM View
adrenergic receptor, alpha 1b DROPERIDOL Adrenergic alpha1B 100% .018uM .00978uM View
sodium channel, voltage-gated, type IV, beta DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel associated protein 1 DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel associated protein 2 DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type III, beta DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type I, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type IX, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type VII, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
amiloride-sensitive cation channel 5, intestinal DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type III, beta DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type XI, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type I, beta DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type 10, alpha polypeptide DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type IV, alpha polypeptide DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type V, alpha polypeptide DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type II, beta DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, nonvoltage-gated 1 alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
calcium channel, voltage-dependent, gamma subunit 2 BENZETHONIUM CHLORIDE Calcium Channel Type L, Benzothiazepine 99% 1.403uM 1.247uM View
calcium channel, voltage-dependent, gamma subunit 1 BENZETHONIUM CHLORIDE Calcium Channel Type L, Benzothiazepine 99% 1.403uM 1.247uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) RITONAVIR Sodium Channel, Site 2 99% 2.379uM 2.133uM View
sodium channel, voltage-gated, type IV, beta RITONAVIR Sodium Channel, Site 2 99% 2.379uM 2.133uM View
sodium channel, voltage-gated, type IV, alpha RITONAVIR Sodium Channel, Site 2 99% 2.379uM 2.133uM View
sodium channel, voltage-gated, type III, alpha RITONAVIR Sodium Channel, Site 2 99% 2.379uM 2.133uM View
sodium channel, voltage-gated, type II, beta RITONAVIR Sodium Channel, Site 2 99% 2.379uM 2.133uM View
sodium channel, voltage-gated, type II, alpha 2 RITONAVIR Sodium Channel, Site 2 99% 2.379uM 2.133uM View
sodium channel, voltage-gated, type I, beta RITONAVIR Sodium Channel, Site 2 99% 2.379uM 2.133uM View
sodium channel, voltage-gated, type I, alpha RITONAVIR Sodium Channel, Site 2 99% 2.379uM 2.133uM View
5-hydroxytryptamine (serotonin) receptor 2A OLANZAPINE Serotonin 5-HT2A 99% .005016uM .001433uM View
adrenergic receptor, alpha 1a OLANZAPINE Adrenergic alpha1A 99% .065uM .026uM View
androgen receptor NANDROLONE Testosterone 99% .003149uM .002099uM View
cholinergic receptor, muscarinic 3 NORTRIPTYLINE Muscarinic M3 99% .171uM .036uM View
cholinergic receptor, muscarinic 5 OLANZAPINE Muscarinic M5 99% .04uM .029uM View
cholinergic receptor, nicotinic, alpha polypeptide 9 NICOTINE Nicotinic Acetylcholine, Central 99% .012uM .004123uM View
cholinergic receptor, nicotinic, alpha polypeptide 10 NICOTINE Nicotinic Acetylcholine, Central 99% .012uM .004123uM View
cholinergic receptor, nicotinic, epsilon polypeptide NICOTINE Nicotinic Acetylcholine, Central 99% .012uM .004123uM View
cholinergic receptor, nicotinic, beta polypeptide 4 NICOTINE Nicotinic Acetylcholine, Central 99% .012uM .004123uM View
cholinergic receptor, nicotinic, alpha polypeptide 5 NICOTINE Nicotinic Acetylcholine, Central 99% .012uM .004123uM View
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) NICOTINE Nicotinic Acetylcholine, Central 99% .012uM .004123uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 OXICONAZOLE Dopamine Transporter 99% 2.6555uM 2.1098uM View
opioid receptor, sigma 1 OXYBUTYNIN Sigma1 99% .0242uM .0102uM View
cholinergic receptor, muscarinic 1 ORPHENADRINE Muscarinic M1 99% .148uM .036uM View
cholinergic receptor, muscarinic 3 ORPHENADRINE Muscarinic M3 99% .175uM .037uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 EBASTINE Adrenergic, Norepinephrine Transporter 99% .4603uM .4564uM View
cholinergic receptor, muscarinic 5 ORPHENADRINE Muscarinic M5 99% .028uM .02uM View
adrenergic receptor, alpha 1b EBASTINE Adrenergic alpha1B 99% .4207uM .2329uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 EBASTINE Dopamine Transporter 99% .0987uM .0784uM View
cholinergic receptor, muscarinic 1 EBASTINE Muscarinic M1 99% .4203uM .1012uM View
epidermal growth factor receptor CADMIUM CHLORIDE Protein Tyrosine Kinase, EGF Receptor 99% .486uM NoneNone View
dopamine receptor D3 PROMETHAZINE Dopamine D3 99% .559uM .19uM View
5-hydroxytryptamine (serotonin) receptor 2B PROMETHAZINE Serotonin 5-HT2B 99% .068uM .043uM View
histamine receptor H 1 PROMETHAZINE Histamine H1, Central 99% .002871uM .000334uM View
adrenergic receptor, alpha 2a CETYLPYRIDINIUM BROMIDE Adrenergic alpha2A 99% .242uM .091uM View
estrogen receptor 1 STANOZOLOL Estrogen ERalpha 99% .113uM .032uM View
estrogen receptor 1 STANOZOLOL Estrogen ERalpha 99% .113uM .032uM View
Protein-tyrosine kinase, Fyn BENZETHONIUM CHLORIDE Protein Tyrosine Kinase, Fyn 99% .768uM NoneNone View
cholinergic receptor, muscarinic 2 BENZETHONIUM CHLORIDE Muscarinic M2 99% .574uM .204uM View
adrenergic receptor, alpha 1d (Non-specific probe) PHENTOLAMINE Adrenergic alpha1D 99% .022uM .011uM View
calcium channel, voltage-dependent, gamma subunit 8 BENZETHONIUM CHLORIDE Calcium Channel Type L, Benzothiazepine 99% 1.403uM 1.247uM View
calcium channel, voltage-dependent, gamma subunit 7 BENZETHONIUM CHLORIDE Calcium Channel Type L, Benzothiazepine 99% 1.403uM 1.247uM View
calcium channel, voltage-dependent, gamma subunit 6 BENZETHONIUM CHLORIDE Calcium Channel Type L, Benzothiazepine 99% 1.403uM 1.247uM View
calcium channel, voltage-dependent, gamma subunit 5 BENZETHONIUM CHLORIDE Calcium Channel Type L, Benzothiazepine 99% 1.403uM 1.247uM View
calcium channel, voltage-dependent, gamma subunit 4 BENZETHONIUM CHLORIDE Calcium Channel Type L, Benzothiazepine 99% 1.403uM 1.247uM View
calcium channel, voltage-dependent, gamma subunit 3 BENZETHONIUM CHLORIDE Calcium Channel Type L, Benzothiazepine 99% 1.403uM 1.247uM View
gamma-aminobutyric acid A receptor, delta FLUMAZENIL GABAA, Benzodiazepine, Central 99% .003867uM .003151uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 FLUMAZENIL GABAA, Benzodiazepine, Central 99% .003867uM .003151uM View
adrenergic receptor, alpha 2b FLUPHENAZINE Adrenergic alpha2C 99% .154uM .022uM View
adrenergic receptor, alpha 2c (Non-specific probe) FLUPHENAZINE Adrenergic alpha2C 99% .154uM .022uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 DEXTROMETHORPHAN Serotonin Transporter 99% .00271uM .00144uM View
epidermal growth factor receptor CAFFEIC ACID PHENETHYL ESTER Protein Tyrosine Kinase, EGF Receptor 99% 1.005uM NoneNone View
cholinergic receptor, muscarinic 4 DOXEPIN Muscarinic M4 99% .042uM .005842uM View
5-hydroxytryptamine (serotonin) receptor 2B DOXEPIN Serotonin 5-HT2B 99% .089uM .056uM View
adrenergic receptor, alpha 2b TICLOPIDINE Adrenergic alpha2B 99% .304uM .139uM View
nuclear receptor subfamily 3, group C, member 1 MEGESTROL ACETATE Glucocorticoid 99% .019uM .008769uM View
opioid receptor, sigma 1 HALOPERIDOL Sigma1 99% .013uM .005665uM View
dopamine receptor 2 HALOPERIDOL Dopamine D2L 99% .006592uM .002197uM View
estrogen receptor 1 GENISTEIN Estrogen ERalpha 99% .135uM .039uM View
estrogen receptor 1 GENISTEIN Estrogen ERalpha 99% .135uM .039uM View
adrenergic receptor, alpha 1b TRAZODONE Adrenergic alpha1B 99% .111uM .061uM View
adrenergic receptor, alpha 2b THIORIDAZINE Adrenergic alpha2C 99% .171uM .025uM View
adrenergic receptor, alpha 2c (Non-specific probe) THIORIDAZINE Adrenergic alpha2C 99% .171uM .025uM View
adrenergic receptor, alpha 2a BROMOCRIPTINE Adrenergic alpha2A 99% .015uM .005533uM View
dopamine receptor D3 VERAPAMIL Dopamine D3 99% .186uM .063uM View
adrenergic receptor, alpha 1a BROMOCRIPTINE Adrenergic alpha1A 99% .00696uM .002817uM View
adrenergic receptor, beta 2 PROPAFENONE Adrenergic beta2 99% .052uM .036uM View
adrenergic receptor, alpha 1b BROMOCRIPTINE Adrenergic alpha1B 99% .003547uM .001964uM View
5-hydroxytryptamine (serotonin) receptor 1A BROMOCRIPTINE Serotonin 5-HT1A 99% .005635uM .00322uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 CITALOPRAM Serotonin Transporter 99% .000902uM .000479uM View
adrenergic receptor, alpha 1d (Non-specific probe) MIANSERIN Adrenergic alpha1D 99% .083uM .041uM View
5-hydroxytryptamine (serotonin) receptor 2B LYSERGOL Serotonin 5-HT2B 99% .033uM .021uM View
adrenergic receptor, alpha 1b MIANSERIN Adrenergic alpha1B 99% .119uM .066uM View